Systemic correlates of cutaneous manifestations of lupus erythematosus
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.17178 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Peter M Heil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous, Photosensitivity Disorders, Antibodies, Antinuclear. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
We aimed to investigate the prevalence of skin disease among patients with systemic lupus erythematosus (SLE) and determine whether LE skin disease had clinical or serologic correlates with SLE.
Methods
We reviewed records of 335 patients with SLE (seen at Mayo Clinic, Rochester, Minnesota, USA) and abstracted skin manifestations, fulfilled mucocutaneous SLE criteria, and clinical and serologic parameters.
Results
Of the 231 patients with skin manifestations, 57 (24.7%) had LE‐specific conditions, 102 (44.2%) had LE‐nonspecific conditions, and 72 (31.2%) had both. LE skin disease was associated with photosensitivity, anti‐Smith antibodies, and anti‐U1RNP antibodies (all P < 0.001). Patients without LE skin disease more commonly had elevated C‐reactive protein levels ( P = 0.01). Patients meeting 2–4 mucocutaneous American College of Rheumatology criteria less commonly had cytopenia ( P = 0.004) or anti−double‐stranded DNA antibodies ( P = 0.004). No significant associations were observed for systemic involvement (renal, hematologic, neurologic, and arthritis) when comparing patients with or without LE skin involvement. LE skin involvement was not significantly associated with internal SLE disease flare, number of medications, or overall survival.
Conclusions
LE skin disease commonly occurs in patients with SLE. The presence of LE skin disease had no mitigating impact on the severity of SLE sequelae, disease flares, number of medications, or overall survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.
- Visiting Research Fellow, Mayo Clinic, Rochester, MN, USA.
- Department of Dermatology, Mayo Clinic, Scottsdale, AZ, USA.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
- Department of Dermatology, Mayo Clinic, Jacksonville, FL, USA.
- Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Peter M Heil, Olayemi Sokumbi
Zitieren
APA
Heil, P. M., Pittelkow, M. R., Weaver, A. L., Killian, J. M., Sokumbi, O., & Wetter, D. A. (2024). Systemic correlates of cutaneous manifestations of lupus erythematosus. International Journal of Dermatology. https://doi.org/10.1111/ijd.17178
Vancouver
Heil PM, Pittelkow MR, Weaver AL, Killian JM, Sokumbi O, Wetter DA. Systemic correlates of cutaneous manifestations of lupus erythematosus. International Journal of Dermatology. 2024. doi:10.1111/ijd.17178
BibTeX
@article{Heil2024,
author = {Heil, Peter M and Pittelkow, Mark R and Weaver, Amy L and Killian, Jill M and Sokumbi, Olayemi and Wetter, David A},
title = {Systemic correlates of cutaneous manifestations of lupus erythematosus},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.17178}
}
EUVIMED